{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:58:29Z","timestamp":1787021909659,"version":"build-2736575974"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,31]],"date-time":"2013-12-31T00:00:00Z","timestamp":1388448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0083849","type":"journal-article","created":{"date-parts":[[2013,12,31]],"date-time":"2013-12-31T17:03:44Z","timestamp":1388509424000},"page":"e83849","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Multi-Indication Carbamazepine and the Risk of Severe Cutaneous Adverse Drug Reactions in Korean Elderly Patients: A Korean Health Insurance Data-Based Study"],"prefix":"10.1371","volume":"8","author":[{"given":"Ji Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joongyub","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Jin","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Young","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam-Kyong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Joo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,12,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1212\/WNL.0b013e31823b478c","article-title":"Severe cutaneous adverse reactions to antiepileptic drugs in Asians","volume":"77","author":"CY Yang","year":"2011","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics","volume":"64","author":"M Mockenhaupt","year":"2005","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0140-6736(98)05418-X","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions","volume":"353","author":"B Rzany","year":"1999","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/pds.1871","article-title":"Antiepileptic drugs in Australia: 2002\u20132007","volume":"19","author":"SA Hollingworth","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.07.005","article-title":"Antiepileptic drugs in epilepsy and other disorders-a population-based study of prescriptions","volume":"87","author":"C Johannessen Landmark","year":"2009","journal-title":"Epilepsy Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0404.2006.00639.x","article-title":"Trends in utilization of antiepileptic drugs in Denmark","volume":"113","author":"I Tsiropoulos","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.clineuro.2007.07.002","article-title":"Epileptic fits and epilepsy in the elderly: general reflections, specific issues and therapeutic implications","volume":"109","author":"RV Sheorajpanday","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2165\/00002512-200219120-00004","article-title":"Management strategies for the treatment of neuropathic pain in the elderly","volume":"19","author":"M Ahmad","year":"2002","journal-title":"Drugs Aging"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s40262-013-0067-4","article-title":"Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an update","volume":"52","author":"D Italiano","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1532-5415.2004.52367.x","article-title":"Risk factors for adverse drug events among older adults in the ambulatory setting","volume":"52","author":"TS Field","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.amjopharm.2007.03.004","article-title":"Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population?","volume":"5","author":"JL Green","year":"2007","journal-title":"Am J Geriatr Pharmacother"},{"key":"ref12","first-page":"41","article-title":"Adverse drug effects in hospitalized elderly: data from the healthcare cost and utilization project","volume":"2","author":"T Shamliyan","year":"2010","journal-title":"Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","author":"M Pirmohamed","year":"2004","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clindermatol.2010.07.006","article-title":"Drug eruptions in the elderly","volume":"29","author":"SC Carneiro","year":"2011","journal-title":"Clin Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990\u20131992): structure and results of a population-based registry","volume":"49","author":"B Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"S Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"P Sekula","year":"2013","journal-title":"J Invest Dermatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/JCP.0b013e3181845610","article-title":"The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study","volume":"28","author":"SS Gau","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s00535-012-0722-9","article-title":"A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate","volume":"48","author":"J Lee","year":"2013","journal-title":"J Gastroenterol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3748\/wjg.v17.i5.651","article-title":"A population-based case-crossover study of polyethylene glycol use and acute renal failure risk in the elderly","volume":"17","author":"NK Choi","year":"2011","journal-title":"World J Gastroenterol"},{"key":"ref21","unstructured":"Park BJ, Sung JH, Park KD (2003) Report of the evaluation for validity of discharged diagnoses in Korean Health Insurance database [ in Korean]. Seoul: Seoul National University."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan","volume":"364","author":"P Chen","year":"2011","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1445-5994.2005.00790.x","article-title":"Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study","volume":"35","author":"MS Lin","year":"2005","journal-title":"Intern Med J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archderm.1991.01680050075007","article-title":"A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures","volume":"127","author":"BL Strom","year":"1991","journal-title":"Arch Dermatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1750-1172-6-52","article-title":"Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe","volume":"6","author":"E Genin","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"JC Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"H Quan","year":"2005","journal-title":"Medical Care"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"M Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1542\/peds.2008-1923","article-title":"Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis","volume":"123","author":"N Levi","year":"2009","journal-title":"Pediatrics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/ageing\/22.6.450","article-title":"Toxic epidermal necrolysis (Lyell syndrome) in 77 elderly patients","volume":"22","author":"S Bastuji-Garin","year":"1993","journal-title":"Age Ageing"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1001\/archinte.1993.00410110088014","article-title":"Stevens-Johnson syndrome associated with herpes simplex virus","volume":"153","author":"HE Golden","year":"1993","journal-title":"Arch Intern Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2133.1996.tb03598.x","article-title":"Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"135","author":"B Rzany","year":"1996","journal-title":"Br J Dermatol"},{"key":"ref33","first-page":"455","article-title":"Stevens-Johnson syndrome associated with gabapentin","volume":"105","author":"L Gonzalez-Sicilia","year":"1998","journal-title":"Am J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00007691-199902000-00022","article-title":"Skin eruption with gabapentin in a patient with repeated AED-induced Stevens-Johnson's syndrome","volume":"21","author":"JC DeToledo","year":"1999","journal-title":"Ther Drug Monit"},{"key":"ref35","first-page":"283","article-title":"A Case of Stevens-Johnson Syndrome Induced by Gabapentin [ in Korean]","volume":"27","author":"JE Ma","year":"2007","journal-title":"Korean J Asthma Allergy Clin Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/11532540-000000000-00000","article-title":"New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited","volume":"33","author":"P Paquet","year":"2010","journal-title":"Drug Saf"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1398-9995.2006.01295.x","article-title":"Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series","volume":"62","author":"LW Yip","year":"2007","journal-title":"Allergy"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","article-title":"Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans","volume":"97","author":"SH Kim","year":"2011","journal-title":"Epilepsy Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2296-9-26","article-title":"Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002\u20132005","volume":"9","author":"GC Hall","year":"2008","journal-title":"BMC Fam Pract"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Wiffen PJ, Derry S, Moore RA, McQuay HJ (2011) Carbamazepine for acute and chronic pain in adults. Cochrane Database Syst Rev: CD005451.","DOI":"10.1002\/14651858.CD005451.pub2"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14740330903427969","article-title":"Genetic predisposition of life-threatening antiepileptic-induced skin reactions","volume":"9","author":"WH Chung","year":"2010","journal-title":"Expert Opin Drug Saf"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0083849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T01:14:12Z","timestamp":1597281252000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0083849"}},"subtitle":[],"editor":[{"given":"Alfonso","family":"Carvajal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,31]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0083849","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,31]]}}}